Whac-a-mole: Future trends in Chagas transmission and the importance of a global perspective on disease control

Future Microbiology

Volumn 2, Issue 4, 2007, Pages 365-367

  Dorn, Patricia ^a   Buekens, Pierre ^b   Hanford, Elaine ^c  

^a LOYOLA UNIVERSITY   (United States)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Department of Geology and Environmental Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD ANALYSIS; CAUSE OF DEATH; CHAGAS DISEASE; CLINICAL FEATURE; DISEASE CARRIER; DISEASE SEVERITY; DISEASE SURVEILLANCE; EDITORIAL; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEALTH PROGRAM; HEALTH PROMOTION; HEART DISEASE; HUMAN; INFECTION CONTROL; INFECTION RISK; MORTALITY; NONHUMAN; PARASITE IDENTIFICATION; PARASITE TRANSMISSION; PARASITE VIRULENCE; POPULATION RESEARCH; PREVALENCE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION; RISK ASSESSMENT; RISK FACTOR; SEROPREVALENCE; TRYPANOSOMA CRUZI; VERTICAL TRANSMISSION;

ANIMALS; CHAGAS DISEASE; ENDEMIC DISEASES; HUMANS; LATIN AMERICA; WORLD HEALTH;

EID: 34548447022     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/17460913.2.4.365     Document Type: Editorial

References (13)

1. Schofield CJ, Jannin J, Salvatella R: The future of Chagas disease control. Trends Parasitol. 22(12), 583-588 (2006).
2. Dias JC, Silveira AC, Schofield CJ: The impact of Chagas disease control in Latin America: a review. Mem. Inst. Oswaldo Cruz. 97(5), 603-612 (2002).
3. Schmunis GA, Cruz JR: Safety of the blood supply in Latin America. Clin. Microbiol. Rev. 18(1), 12-29 (2005).
4. Gürtler RE, Segura EL, Cohen JE: Congenital transmission of Trypanosoma cruzi infection in Argentina. Emerg. Infect. Dis. 9(1), 29-32 (2003).
5. Riera C, Guarro A, Kassab HE et al.: Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report. Am. J. Trop. Med. Hyg. 75(6), 1078-1081 (2006).
6. Hanford EJ, Zhan FB, Lu Y, Giordano A: Chagas disease in Texas: recognizing the significance and implications of evidence in the literature. Soc. Sci. Med. 65(1), 60-79 (2007)
7. Stramer S, Dodd RY, Leiby DA et al.: Blood donor screening for Chagas disease - United States, 2006-2007. MMWR Morb. Mortal. Wkly Rep. 56(7), 141-143 (2007).
8. Leiby DA, Herron RM, Read EJ, Lenes BA, Stumpf RJ: Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 42(5), 549-555 (2002).
9. WHO: Control of Chagas disease (Second Report). In: WHO Technical Report Series 905. WHO (Ed.) World Health Organization, Geneva, Switzerland (2002).
10. Carlier Y, Torrico F: Congenital infection with Trypanosoma cruzi from mechanisms of transmission to strategies for diagnosis and control. Rev. Soc. Bras. Med. Trop. 36, 767-771 (2003).
11. Buekens P, Almendares O, Carlier Y et al.: Mother-to-child transmission of Chagas' disease in North America: why don't we do more? Maternal Child Health J. (2007) DOI: 10.1007/s10995-007-0246-8 (In Press).
12. Dorn P, Perniciaro L, Yabsley M et al.: Autochthonous transmission of Trypanosoma cruzi, Louisiana. Emerg. Infect. Dis. 13, 605-607 (2007).
13. Smith R, Woodward D, Acharya A, Beaglehole R, Drager N: Communicable disease control: a 'Global Public Good' perspective. Health Policy Plan. 19(5), 271-278 (2004).